Mesenchymal stem cells for chronic wounds therapy

Cell and Tissue Banking

Volumn 16, Issue 1, 2015, Pages 19-26

  Zahorec, Peter ^a,b   Koller, Jan ^a,b   Danisovic, Lubos ^a   Bohac, Martin ^a,b  

^a Physics and Informatics   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Chronic wounds; Differentiation; Mesenchymal stem cells; Paracrine signalling; Regeneration

Indexed keywords

EID: 84965176646     PISSN: 13899333     EISSN: 15736814     Source Type: Journal    
DOI: 10.1007/s10561-014-9440-2     Document Type: Review

References (53)

1. Adamkov M, Halasova E, Rajcani J, Bencat M, Vybohova D, Rybarova S, Galbavy S (2011) Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas. Med Sci Monit 17:74–80
2. Adamkov M, Kajo K, Vybohova D, Krajcovic J, Stuller F, Rajcani J (2012) Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma. Neoplasma 59:30–37
3. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O’Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W (2007) Characterization of human embryonic stem cell lines by the international stem cell initiative. Nat Biotechnol 25:803–816
4. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822
5. Cambal M, Labas P, Zonca P, Hrbaty B, Janik M, Polakovicova S (2012) The combined algorithm of venous ulcer therapy. Bratisl Lek Listy 113:285–288
6. Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217:318–324
7. Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC (2009) Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 12:359–366
8. Dennis JE, Carbillet JP, Caplan AI, Charbord P (2002) The STRO-1 + marrow cell population is multipotential. Cells Tissues Organs 170:73–82
9. Diegelmann RF, Evans MC (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9:283–289
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317
11. Dorai AA (2012) Wound care with traditional, complementary and alternative medicine. Indian J Plast Surg 45:418–424
12. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156
13. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267–274
14. Fu X, Fang L, Li X, Cheng B, Sheng Z (2006) Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury. Wound Repair Regen 14:325–335
15. Gottrup F, Apelqvist J, Price P (2010) Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care 19:237–268
16. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827–1835
17. Gruber R, Kandler B, Holzmann P, Vogele-Kadletz M, Losert U, Fischer MB, Watzek G (2005) Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng 11:896–903
18. Hamou C, Callaghan MJ, Thangarajah H, Chang E, Chang EI, Grogan RH, Paterno J, Vial IN, Jazayeri L, Gurtner GC (2009) Mesenchymal stem cells can participate in ischemic neovascularization. Plast Reconstr Surg 123:45–55
19. Harada K, Yamahara K, Ohnishi S, Otani K, Kanoh H, Ishibashi-Ueda H, Minamino N, Kangawa K, Nagaya N, Ikeda T (2011) Sustained-release adrenomedullin ointment accelerates wound healing of pressure ulcers. Regul Pept 168:21–26
20. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030–1041
21. Huang TF, Chen YT, Yang TH, Chen LL, Chiou SH, Tsai TH, Tsai CC, Chen MH, Ma HL, Hung SC (2008) Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament. Cytotherapy 10:806–814
22. Jackson WM, Nesti LJ, Tuan RS (2012) Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med 1:44–50
23. Karp JM, Leng Teo GS (2009) Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4(3):206–216
24. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, Mongan NP (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18:1093–1108
25. Keating A, Singer JW, Killen PD, Striker GE, Salo AC, Sanders J, Thomas ED, Thorning D, Fialkow PJ (1982) Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature 298:280–283
26. Kestendjieva S, Kyurkchiev D, Tsvetkova G, Mehandjiev T, Dimitrov A, Nikolov A, Kyurkchiev S (2008) Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int 32:724–732
27. Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204
28. Li L, Jiang J (2011) Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms. Front Med 5:33–39
29. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, Flake AW (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282–1286
30. Lozito TP, Kuo CK, Taboas JM, Tuan RS (2009) Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem 107:714–722
31. Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, Xu J, Wu Q, Zhang Z, Xie B, Chen S (2011) Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 92:26–36
32. Maeda T, Kurita R, Yokoo T, Tani K, Makino N (2011) Telomerase inhibition promotes an initial step of cell differentiation of primate embryonic stem cell. Biochem Biophys Res Commun 407:491–494
33. Maximow A (1909) Der Lymphozyt als gemeinsame Stammzelle der verschiedenen Blutelemente in der embryonalen Entwicklung und im postfetalen Leben der Säugetiere. Folia Haematologica 8:125–134
34. Maxson S, Erasmo AL, Yoo D, Danilkovitch-Miagkova A, Leroux M (2012) Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Trans Med 1:142–149
35. Oberyszyn TM (2007) Inflammation and wound healing. Front Biosci 12:2993–2999
36. Pappenheim A (1917) Prinzipien der neueren morphologischen Haematozytologie nach zytogenetischer Grundlage. Folia Haematol (Lipz.) 21:91
37. Patterson M, Chan DN, Ha I, Case D, Cui Y, Van Handel B, Mikkola HK, Lowry WE (2012) Defining the nature of human pluripotent stem cell progeny. Cell Res 22:178–193
38. Procházka V, Gumulec J, Jalůvka F, Salounová D, Jonszta T, Czerný D, Krajča J, Urbanec R, Klement P, Martinek J, Klement GL (2010) Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 19:1413–1424
39. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Stem Cell 2:141–150
40. Renault MA, Roncalli J, Tongers J, Misener S, Thorne T, Jujo K, Ito A, Clarke T, Fung C, Millay M, Kamide C, Scarpelli A, Klyachko E, Losordo DW (2009) The Hedgehog transcription factor Gli3 modulates angiogenesis. Circ Res 105:818–826
41. Rojewski MT, Weber BM, Schrezenmeier H (2008) Phenotypic characterization of mesenchymal stem cells from various tissues. Transfus Med Hemother 35:168–184
42. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H (2008) Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180:2581–2587
43. Shanti RM, Li WJ, Nesti LJ, Wang X, Tuan RS (2007) Adult mesenchymal stem cells: biological properties, characteristics, and applications in maxillofacial surgery. J Oral Maxillofac Surg 65:1640–1647
44. Silver GA (1987) Virchov, the heroic model in medicine: health policy by accolade. Am J Public Health 77:82–88
45. Siminovitch L, McMulloch EA, Till JE (1963) The distribution of colony- forming cells among spleen colonies. J Cell Physiol 62:327–336
46. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
47. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
48. Tapp H, Hanley EN Jr, Patt JC, Gruber HE (2009) Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med (Maywood) 234:1–9
49. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
50. Till JE, McCulloch EA (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation res 14:213–222
51. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, Yarmush ML (2010) Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19:667–679
52. Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y, Takakura Y, Okuchi K, Nonomura A (2008) Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 121:860–877
53. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920